Changes

8,543 bytes added ,  18:04, 7 July 2016
Line 772: Line 772:  
== WHO Classification of Tumours of the Digestive System (2010) ==
 
== WHO Classification of Tumours of the Digestive System (2010) ==
   −
== WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2008) ==  
+
== WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2008) ==
 +
 
 +
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px">
 +
'''Myeloproliferative neoplasms'''
 +
<div class="mw-collapsible-content">
 +
:Chronic myelogenous leukaemia, BCR-ABL1 positive
 +
:Chronic neutrophilic leukaemia
 +
:Polycythaemia vera
 +
:Primary myelofibrosis
 +
:Essential thrombocythaemia
 +
:Chronic eosinophilic leukaemia, NOS
 +
:Mastocytosis
 +
:Cutaneous mastocytosis
 +
:Systemic mastocytosis
 +
:Mast cell leukaemia
 +
:Mast cell sarcoma
 +
:Extracutaneous mastocytoma
 +
:Myeloproliferative neoplasm, unclassifiable
 +
</div>
 +
</div>
 +
 
 +
'''Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA,PDGFRB or FGFR1'''
 +
 
 +
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px">
 +
'''Myelodysplastic/myeloproliferative neoplasms'''
 +
<div class="mw-collapsible-content">
 +
:Chronic myelomonocytic leukaemia
 +
:Atypical chronic myeloid leukaemia, BCR-ABL1 negative
 +
:Juvenile myelomonocytic leukaemia
 +
:Myelodysplastic/myeloproliferative neoplasm, unclassifiable
 +
</div>
 +
</div>
 +
 
 +
 
 +
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px">
 +
'''Myelodysplastic syndromes'''
 +
<div class="mw-collapsible-content">
 +
:Myelodysplastic syndromes/neoplasms, overview
 +
:Refractory cytopenia with unilineage dysplasia
 +
:Refractory anaemia with ring sideroblasts
 +
:Refractory cytopenia with multilineage dysplasia
 +
:Refractory anaemia with excess blasts
 +
:Myelodysplastic syndrome with isolated del(5q)
 +
:Myelodysplastic syndrome, unclassifiable
 +
:Childhood myelodysplastic syndrome
 +
:Refractory cytopenia of childhood
 +
</div>
 +
</div>
 +
 
 +
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px">
 +
'''Acute myeloid leukaemia (AML) and related precursor neoplasms'''
 +
<div class="mw-collapsible-content">
 +
:AML with recurrent genetic abnormalities
 +
:AML with t(8;21)(q22;q22); RUNX1-RUNX1T1
 +
:AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11
 +
:Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA
 +
:AML with t(9;11)(p22;q23); MLLT3-MLL
 +
:AML with t(6;9)(p23;q34); DEK-NUP214v AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2);RPN1-EVI1
 +
:AML (megakaryoblastic) with t(1;22)(p13;q13);RBM15-MKL1
 +
:AML with mutated NPM1
 +
:AML with mutated CEBPA
 +
:AML with myelodysplasia-related changes
 +
:Therapy-related myeloid neoplasms
 +
:Acute myeloid leukaemia, NOS
 +
:AML with minimal differentiation
 +
:AML without maturation
 +
:AML with maturation
 +
:Acute myelomonocytic leukaemia
 +
:Acute monoblastic and monocytic leukaemia
 +
:Acute erythroid leukaemia
 +
:Acute megakaryoblastic leukaemia
 +
:Acute basophilic leukaemia
 +
:Acute panmyelosis with myelofibrosis
 +
:Myeloid sarcoma
 +
:Myeloid proliferations related to Down syndrome
 +
:Transient abnormal myelopoiesis
 +
:Myeloid leukaemia associated with Down syndrome
 +
:Blastic plasmacytoid dendritic cell neoplasm
 +
</div>
 +
</div>
 +
 
 +
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px">
 +
'''Acute leukaemias of ambiguous lineage'''
 +
<div class="mw-collapsible-content">
 +
:Acute undifferentiated leukaemia
 +
:Mixed phenotype acute leukaemia with t(9;22)(q34;q11.2); BCR-ABL1
 +
:Mixed phenotype acute leukaemia with t(v;11q23); MLL rearranged
 +
:Mixed phenotype acute leukaemia, B/myeloid, NOS 152
 +
:Mixed phenotype acute leukaemia, T/myeloid, NOS 153
 +
:Mixed phenotype acute leukaemia, NOS - rare types
 +
:Other ambiguous lineage leukaemias
 +
:Natural killer (NK)-cell lymphoblastic leukaemia/lymphoma
 +
</div>
 +
</div>
 +
 
 +
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px">
 +
'''Precursor lymphoid neoplasms'''
 +
<div class="mw-collapsible-content">
 +
:B lymphoblastic leukaemia/lymphoma, NOS
 +
:B lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities
 +
:B lymphoblastic leukaemia/lymphoma with t(9:22)(q34;q11.2); BCR-ABL1
 +
:B lymphoblastic leukaemia/lymphoma with t(v;11q23); MLL rearranged
 +
:B lymphoblastic leukaemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)
 +
:B lymphoblastic leukaemia/lymphoma with hyperdiploidy
 +
:B lymphoblastic leukaemia/lymphoma with hypodiploidy (Hypodiploid ALL)
 +
:B lymphoblastic leukaemia/lymphoma with t(5;14)(q31;q32); IL3-IGH
 +
:B lymphoblastic leukaemia/lymphoma with t(1;19) (q23;p13.3); E2A-PBX1(TCF3-PBX1)
 +
:T lymphoblastic leukaemia/lymphoma
 +
</div>
 +
</div>
 +
 
 +
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px">
 +
'''Mature B-cell neoplasms'''
 +
<div class="mw-collapsible-content">
 +
:Chronic lymphocytic leukaemia /small lymphocytic lymphoma
 +
:B-cell prolymphocytic leukaemia
 +
:Splenic marginal zone lymphoma
 +
:Hairy cell leukaemia
 +
:Splenic B-cell lymphoma/leukaemia, unclassifiable
 +
:Splenic diffuse red pulp small B-cell lymphoma
 +
:Hairy cell leukaemia-variant
 +
:Lymphoplasmacytic lymphoma
 +
:Heavy chain diseases
 +
:Gamma heavy chain disease
 +
:Mu heavy chain disease
 +
:Alpha heavy chain disease
 +
:Plasma cell neoplasms
 +
:Monoclonal gammopathy of undetermined significance (MGUS)
 +
:Plasma cell myeloma
 +
:Solitary plasmacytoma of bone
 +
:Extraosseous plasmacytoma
 +
:Monoclonal immunoglobulin deposition diseases
 +
:Extranodal marginal zone lymphoma of mucosa- associated lymphoid tissue (MALT lymphoma)
 +
:Nodal marginal zone lymphoma
 +
:Follicular lymphoma
 +
:Primary cutaneous follicle centre lymphoma
 +
:Mantle cell lymphoma
 +
:Diffuse large B-cell lymphoma (DLBCL), NOS
 +
:T cell/histiocyte-rich large B-cell lymphoma
 +
:Primary DLBCL of the CNS
 +
:Primary cutaneous DLBCL, leg type
 +
:EBV positive DLBCL of the elderly
 +
:DLBCL associated with chronic inflammation
 +
:Lymphomatoid granulomatosis
 +
:Primary mediastinal (thymic) large B-cell lymphoma
 +
:Intravascular large B-cell lymphoma
 +
:ALK positive large B-cell lymphoma
 +
:Plasmablastic lymphoma
 +
:Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease
 +
:Primary effusion lymphoma
 +
:Burkitt lymphoma
 +
:B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma
 +
:B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma
 +
</div>
 +
</div>
 +
 
 +
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px">
 +
'''Mature T- and NK-cell neoplasms'''
 +
<div class="mw-collapsible-content">
 +
:T-cell prolymphocytic leukaemia
 +
:T-cell large granular lymphocytic leukaemia
 +
:Chronic lymphoproliferative disorder of NK cells
 +
:Aggressive NK cell leukaemia
 +
:Epstein-Barr virus (EBV) positive T-cell lymphoproliferative diseases of childhood
 +
:Systemic EBV+ T-cell lymphoproliferative disease of childhood
 +
:Hydroa vacciniforme-like lymphoma
 +
:Adult T-cell leukaemia/lymphoma
 +
:Extranodal NK/T-cell lymphoma, nasal type
 +
:Enteropathy-associated T-cell lymphoma
 +
:Hepatosplenic T-cell lymphoma
 +
:Subcutaneous panniculitis-like T-cell lymphoma
 +
:Mycosis fungoides
 +
:Sézary syndrome
 +
:Primary cutaneous CD30 positive T-cell lymphoproliferative disorders
 +
:Primary cutaneous peripheral T-cell lymphomas, rare subtypes
 +
:Primary cutaneous gamma-delta T-cell lymphoma
 +
:Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma
 +
:Primary cutaneous CD4 positive small/medium T-cell lymphoma
 +
:Peripheral T-cell lymphoma, NOS
 +
:Angioimmunoblastic T-cell lymphoma
 +
:Anaplastic large cell lymphoma, ALK positive
 +
:Anaplastic large cell lymphoma, ALK negative
 +
</div>
 +
</div>
 +
 
 +
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px">
 +
'''Hodgkin lymphoma'''
 +
<div class="mw-collapsible-content">
 +
:Nodular lymphocyte predominant Hodgkin lymphoma
 +
:Classical Hodgkin lymphoma
 +
:Nodular sclerosis classical Hodgkin lymphoma
 +
:Mixed cellularity classical Hodgkin lymphoma
 +
:Lymphocyte-rich classical Hodgkin lymphoma
 +
:Lymphocyte-depleted classical Hodgkin lymphoma
 +
</div>
 +
</div>
 +
 
 +
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px">
 +
'''Immunodeficiency-associated lymphoproliferative disorders'''
 +
<div class="mw-collapsible-content">
 +
:Lymphoproliferative diseases associated with primary immune disorders
 +
:Lymphomas associated with HIV infection
 +
:Post-transplant lymphoproliferative disorders (PTLD)
 +
:Plasmacytic hyperplasia and infectious- mononucleosis-like PTLD
 +
:Polymorphic PTLD
 +
:Monomorphic PTLD
 +
:Classical Hodgkin lymphoma type PTLD
 +
:Other iatrogenic immunodeficiency-associated lymphoproliferative disorders
 +
</div>
 +
</div>
 +
 
 +
<div class="toccolours mw-collapsible mw-collapsed" style="width:800px">
 +
'''Histiocytic and dendritic cell neoplasms'''
 +
<div class="mw-collapsible-content">
 +
:Histiocytic sarcoma
 +
:Tumours derived from Langerhans cells
 +
:Langerhans cell histiocytosis
 +
:Langerhans cell sarcoma
 +
:Interdigitating dendritic cell sarcoma
 +
:Follicular dendritic cell sarcoma
 +
:Other rare dendritic cell tumours
 +
:Disseminated juvenile xanthogranuloma
 +
</div>
 +
</div>
    
== Miscellaneous Cancer Types ==
 
== Miscellaneous Cancer Types ==